-
Company Insights
NewElevance Health – Digital Transformation Strategies
Elevance Health Digital Transformation Strategies Overview Elevance Health is tapping the power of big data analytics to analyze data and generate insights, improve member engagement, and detect fraudulent claims. AI, big data, cloud, and automation are among the key technologies under focus for the company. The annual ICT spending of Elevance Health was estimated at $3.8 billion in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. Elevance Health Inc...
-
Sector Analysis
NewDenmark Beverages Consumption Trends and Forecasts Tracker, Q4 2023
Denmark Beverages Market Overview The Denmark beverages market size was 874.2 million liters (ML) in Q4 2023. The Denmark beverages market research report offers comprehensive consumption volume data across several beverage categories for Q4 2023. Furthermore, the report precisely lists new product launches and highlights the latest beverage industry performance and developments every quarter. The Denmark beverages market outlook also identifies drivers influencing the segmental growth. For instance, packaged water registered an annual volume decline due to low purchasing power...
-
Company Insights
NewKingfisher – Digital Transformation Strategies
Kingfisher Digital Transformation Strategies Overview Kingfisher has been focusing on using artificial intelligence, cloud-based mobile applications, big data, and augmented reality to digitally transform its operations. The annual ICT spending of Kingfisher was estimated at $369.9 million for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Kingfisher sells home improvement products and offers home improvement services to consumers and trade professionals in eight European countries. It operates under the B&Q,...
-
Product Insights
NewSpinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Analyst Opinions
NewTop Trends in Foodservice – Industry Insights
Top Trends in Foodservice Report Overview The foodservice industry has rebounded from the pandemic and has drastically changed consumer behaviour vis-Ã -vis, placing orders, payment options, food choices, and consumption patterns. Asia remains the largest foodservice market globally, with the second-highest transaction growth because of the integration of technology in foodservice operations. This is making it easier and more efficient to order food, access a wider range of choices, and have food delivered from a digital device. The trends in the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anetumab Ravtansine in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anetumab Ravtansine in Metastatic Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anetumab Ravtansine in Metastatic Pancreatic Cancer Drug Details: Anetumab ravtansine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anetumab Ravtansine in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anetumab Ravtansine in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anetumab Ravtansine in Endometrial Cancer Drug Details: Anetumab ravtansine (BAY 94-9343)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anetumab Ravtansine in Uterine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anetumab Ravtansine in Uterine Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anetumab Ravtansine in Uterine Cancer Drug Details: Anetumab ravtansine (BAY 94-9343)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anetumab Ravtansine in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anetumab Ravtansine in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anetumab Ravtansine in Fallopian Tube Cancer Drug Details: Anetumab ravtansine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anetumab Ravtansine in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anetumab Ravtansine in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anetumab Ravtansine in Gastroesophageal (GE) Junction Carcinomas Drug Details:...